STEMON Inc. is a specialized cell reprogramming popularization-leading company, opening up a new future using this game changer’s technology. Our mission is to chase a new health for good health and to be a leader in autologous cell therapy with Entr-based automation system.

Stemon Inc. was established in March 2018, and based on our original technologies for cell reprogramming (Entr® technology) and mass production of exosome (Reprosome®) with selective specific factor (cell reprogramming factor) it has developed and produced extracellular vesicles-based therapeutics, medical devices, and dermal and hair care product.

Entr® (ultrasound-directed permeation of E ...